Michael H. Mulroy
Board Member
Lineage Cell Therapeutics, Inc. (LCTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael H. Mulroy
Michael H. Mulroy is recorded as Board Member at Lineage Cell Therapeutics, Inc. (LCTX). Lineage Cell Therapeutics, Inc. reported in an 8-K filed September 7, 2023 that Michael H. Mulroy was appointed director, effective September 6, 2023.
“The Company’s shareholders elected the nine nominees named below to the Company’s board of directors to hold office until the Company’s 2024 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2014-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lineage Cell Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian M. Culley CFO, Board Member
- Jill A. Howe CFO, Board Member
- Alexandra Hernandez Chief Accounting Officer
- Angus C. Russell Board Member
- Anula Jayasuriya Board Member
- Anula Jayasuriya, M.D., Ph.D., M.B.A. Board Member
- Brian Culley Board Member
- Deborah Andrews Board Member
- Dipti Amin Board Member
- Don Bailey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.